BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced that the Company will hold 2021 R&D Day themed on �Science Drives Innovation in Beijing from 9:00 a.m. to 12:00 p.m. on April 15, 2021. InnoCare Management Team will share with the investors the latest development of the companys research and development, pre-clinical programs and clinical trials.
Investors who have interest can click the below link to submit participation information.
https://www.wjx.top/vj/exc203e.aspx
About InnoCare
InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune diseases with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey, and Boston.
Contacts
Media
Chunhua Lu
86-10-66609879
chunhua.lu@innocarepharma.com
Investor Relations
86-10-66609999
ir@innocarepharma.com
FUZHOU, CHINA - Media OutReach Newswire - 25 May 2024 - To enhance the impact…
The satellite was the first of two that will launch on Electron for NASA’s PREFIRE…
What’s on offer online this week SYDNEY--(BUSINESS WIRE)--The end of another month, but the start…
BEIJING, CHINA - Media OutReach Newswire - 25 May 2024 - The Beijing Inbound Tourism…
Over 100 talented chefs from around the world harnessed the authentic flavours of Lee Kum…
TOKYO--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer,…
